The Dawn of a New Era in Heart Failure Treatment: BioCardia’s CardiAMP Heart Failure II Phase 3 Pivotal Study

BioCardia Logo

In an exciting development for the field of cardiovascular medicine, BioCardia, Inc., a pioneering biotechnology company, has announced the activation of the CardiAMP Heart Failure II Phase 3 pivotal study. This groundbreaking study, recently greenlit by the FDA, represents a significant leap forward in the treatment of ischemic heart failure through advanced cell therapy techniques. […]

Unlock Orthopedic Healing with Wharton’s Jelly Benefits

Benefits of Wharton’s Jelly in orthopedics

Orthopedic healing has taken a giant leap forward with the discovery of the benefits of Wharton’s Jelly stem cells. Derived from the umbilical cord, these remarkable stem cells offer immense promise in the field of regenerative medicine. Their unique properties make them a valuable tool for orthopedic healing, including joint regeneration, tissue engineering, and orthopedic […]

Unlocking Healing: Wharton’s Jelly in Regenerative Medicine

Wharton’s Jelly in regenerative medicine

Wharton’s Jelly, found in the umbilical cord, has emerged as a game-changer in the field of regenerative medicine. Its therapeutic potential lies in its unique ability to release bioactive molecules and factors, known as the secretome, which can promote tissue healing and repair. Wharton’s Jelly stem cells, derived from this gelatinous layer, possess remarkable properties […]